Anti-ADDL monoclonal antibody and use thereof

Details for Australian Patent Application No. 2006306553 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Kinney, Gene; Strohl, William R.; An, Zhiqiang

Agent Freehills

Pub. Number AU-B-2006306553

PCT Pub. Number WO2007/050359

Priority PCT/ US2005/038125 21.10.05 US

Filing date 17 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 25 August 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/050359 Priority application(s): WO2007/050359

25 August 2011 Application Accepted

  Published as AU-B-2006306553

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306563-Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same

2006306552-Method and apparatus for processing heterogeneous units of work